These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1696932)
41. Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. Clements A; Tull D; Jenney AW; Farn JL; Kim SH; Bishop RE; McPhee JB; Hancock RE; Hartland EL; Pearse MJ; Wijburg OL; Jackson DC; McConville MJ; Strugnell RA J Biol Chem; 2007 May; 282(21):15569-77. PubMed ID: 17371870 [TBL] [Abstract][Full Text] [Related]
42. Ribosomes as carriers for antigenic determinants of the surface of micro-organisms. Normier G; Pinel AM; Dussourd d'Hinterland L; Wigzell H; Binz H Dev Biol Stand; 1992; 77():79-85. PubMed ID: 1385236 [TBL] [Abstract][Full Text] [Related]
43. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae. Young LS; Stevens P J Infect Dis; 1977 Aug; 136 Suppl():S174-80. PubMed ID: 19538 [TBL] [Abstract][Full Text] [Related]
44. The ionic interaction of Klebsiella pneumoniae K2 capsule and core lipopolysaccharide. Fresno S; Jiménez N; Izquierdo L; Merino S; Corsaro MM; De Castro C; Parrilli M; Naldi T; Regué M; Tomás JM Microbiology (Reading); 2006 Jun; 152(Pt 6):1807-1818. PubMed ID: 16735743 [TBL] [Abstract][Full Text] [Related]
45. Both clades of the epidemic KPC-producing Klebsiella pneumoniae clone ST258 share a modified galactan O-antigen type. Szijártó V; Guachalla LM; Hartl K; Varga C; Banerjee P; Stojkovic K; Kaszowska M; Nagy E; Lukasiewicz J; Nagy G Int J Med Microbiol; 2016 Feb; 306(2):89-98. PubMed ID: 26723873 [TBL] [Abstract][Full Text] [Related]
46. Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice. Bailat S; Heumann D; Le Roy D; Baumgartner JD; Rietschel ET; Glauser MP; Di Padova F Infect Immun; 1997 Feb; 65(2):811-4. PubMed ID: 9009348 [TBL] [Abstract][Full Text] [Related]
47. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS). Coughlin RT; Bogard WC J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431 [TBL] [Abstract][Full Text] [Related]
49. IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis. Mäki-Ikola O; Lehtinen K; Nissilä M; Granfors K Br J Rheumatol; 1994 Nov; 33(11):1025-9. PubMed ID: 7981989 [TBL] [Abstract][Full Text] [Related]
50. Anti-MrkA Monoclonal Antibodies Reveal Distinct Structural and Antigenic Features of MrkA. Wang Q; Chen Y; Cvitkovic R; Pennini ME; Chang CS; Pelletier M; Bonnell J; Koksal AC; Wu H; Dall'Acqua WF; Stover CK; Xiao X PLoS One; 2017; 12(1):e0170529. PubMed ID: 28107434 [TBL] [Abstract][Full Text] [Related]
51. Surface exposure of O1 serotype lipopolysaccharide in Klebsiella pneumoniae strains expressing different K antigens. Tomás JM; Camprubi S; Merino S; Davey MR; Williams P Infect Immun; 1991 Jun; 59(6):2006-11. PubMed ID: 1709919 [TBL] [Abstract][Full Text] [Related]
52. Monoclonal antibodies to salmonella lipopolysaccharide: functional analysis of anti-lipid A antibodies. Ward DC; Michalek SM; McGhee JR Clin Exp Immunol; 1988 Apr; 72(1):157-63. PubMed ID: 3293850 [TBL] [Abstract][Full Text] [Related]
53. Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae. Lundberg U; Senn BM; Schüler W; Meinke A; Hanner M Hum Vaccin Immunother; 2013 Mar; 9(3):497-505. PubMed ID: 23250007 [TBL] [Abstract][Full Text] [Related]
54. Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides. Parent JB; Gazzano-Santoro H; Wood DM; Lim E; Pruyne PT; Trown PW; Conlon PJ Circ Shock; 1992 Sep; 38(1):63-73. PubMed ID: 1382882 [TBL] [Abstract][Full Text] [Related]
55. Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli. Lun MT; Raponi G; Amatucci AM; Natali PG; Fraioli R; Mancini C J Med Microbiol; 1997 Feb; 46(2):122-8. PubMed ID: 9060871 [TBL] [Abstract][Full Text] [Related]
57. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli. Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054 [TBL] [Abstract][Full Text] [Related]
58. Lipopolysaccharide-induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae. Chathley UC; Sharma S; Chhibber S Folia Microbiol (Praha); 1996; 41(4):373-6. PubMed ID: 9131794 [TBL] [Abstract][Full Text] [Related]
59. Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia. Chhibber S; Wadhwa S; Yadav V Jpn J Infect Dis; 2004 Aug; 57(4):150-5. PubMed ID: 15329446 [TBL] [Abstract][Full Text] [Related]
60. Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens. Cooper JM; Rowley D Aust J Exp Biol Med Sci; 1982 Dec; 60(6):629-41. PubMed ID: 6820634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]